| Record ID | harvard_bibliographic_metadata/ab.bib.14.20150123.full.mrc:31492851:1262 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.14.20150123.full.mrc:31492851:1262?format=raw |
LEADER: 01262cam a2200337Ia 4500
001 014021086-5
005 20140502120232.0
008 930106s1992 mau b 100 0 eng d
035 0 $aocm27204628
040 $aOSU$beng$cOSU$dOCL$dOCLCQ$dOCLCF$dSLR
043 $an-us---
050 4 $aRG137.6.M53$bD48 1992
090 $aRG137.6.M53$bD48 1992
245 04 $aThe Development and use of antiprogestin drugs :$bsocial, political, economic, and legal issues.
260 $aBoston, MA :$bMedicine in the Public Interest,$c[1992]
300 $av, 50, [1] p. ;$c23 cm.
500 $aCover title.
500 $aEdited version of conference held February 6-7, 1992 in Palm Beach, Florida and convened by Medicine in the Public Interest.
504 $aIncludes bibliographical references (p. [51]).
650 0 $aMifepristone$vCongresses.
650 0 $aAbortifacients$vCongresses.
650 0 $aAbortion$xLaw and legislation$zUnited States$vCongresses.
650 7 $aAbortifacients.$2fast
650 7 $aAbortion$xLaw and legislation.$2fast
650 7 $aMifepristone.$2fast
651 7 $aUnited States.$2fast
655 7 $aConference proceedings.$2fast
710 2 $aMedicine in the Public Interest, inc.
988 $a20140502
049 $aSLRR
906 $0OCLC